chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; It started making him feel not so good last night; Has some trouble talking; This is a spontaneous report from two contactable consumer (one was patient). A male patient of an unspecified age received bnt162b2 (BNT162B2, solution for injection, Lot number was not reported) dose number unknown via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medication was not reported. On an unspecified date the patient experienced headache, it started making him feel not so good last night, has some trouble talking. Patient got his Covid vaccination yesterday afternoon by 5'o clock through a pharmacy. He was originally feeling was headache today and all that was listed (voice feeble and incomprehensive). Later Reporter (patient's wife) was over the call and reported that I am his wife. He had some trouble talking. So, he got the vaccine yesterday like in the day. It started making him feel not so good last night. The clinical outcome of the events was unknown.   Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
Low platelets; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (Age: 54; Unit: Unknown) received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced low platelets on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Swelling of right eye; pain; Redness; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Swelling of right eye), PAIN (pain) and ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2020, the patient experienced EYE SWELLING (Swelling of right eye), PAIN (pain) and ERYTHEMA (Redness). At the time of the report, EYE SWELLING (Swelling of right eye), PAIN (pain) and ERYTHEMA (Redness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-010991, MOD-2021-010991 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional information received reporter details updated.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No Medical history reported.).    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided          Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
On  07/19/2022,  in the evening, I had a bad sore throat. Someone in my home had tested positive on 07/17/2022.  On 07/20/2022, I had a low grade fever and maybe nasal congestion.   07/21/2022, I tested positive at home. The low grade fever lasted until 07/22/2022.   Fever and sore throat responded to Tylenol. I did have some muscle aches.
sore throat; difficulty lifting her arm; Chills; Fatigue; headache; pain and tenderness at the injection site; congestion; redness; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), MOBILITY DECREASED (difficulty lifting her arm), NASAL CONGESTION (congestion), ERYTHEMA (redness) and CHILLS (Chills) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced NASAL CONGESTION (congestion), ERYTHEMA (redness) and VACCINATION SITE PAIN (pain and tenderness at the injection site). On 06-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), MOBILITY DECREASED (difficulty lifting her arm), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (headache). At the time of the report, OROPHARYNGEAL PAIN (sore throat), MOBILITY DECREASED (difficulty lifting her arm), NASAL CONGESTION (congestion), ERYTHEMA (redness), CHILLS (Chills), VACCINATION SITE PAIN (pain and tenderness at the injection site), FATIGUE (Fatigue) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided. No concomitant medication information was provided.
pt recv vax & exp redness, hot & swelling @ the inj site w/in 48hr of inj;
large local rxn 3" x 3", red & indurated;lasted for about a wk & resolved;some itching @ site p/1st dose;
Patient came in and her left arm was red, warm to touch from injection site down to her elbow. Marked her redness and swelling with a pen told her to watch if goes outside the area, call Dr. Take antihistamine ranitidine 150 mg x 3 days. Call pharmacy and that I will follow up.
I had a triple bypass 27 years ago. I got a pulmonary embolism the first week in February. I was hospitalized from February 6th through the 10th of 2023. I had never had any issues with my heart. Nothing with blood clots or anything like that. I was exposed to COVID-19 on Tuesday 02/21/2022 of last week. There was a little sneezing and cough. I waited two days before taking a at home test. I was positive. I contacted my doctor that started me on a medicine that starts with a L. It's LAGEVRIO. I will start taking that today for the next five days. I could not take the PAXLOVID due to my blood thinners I take. I was having fatigue. But as of today, I was able to rest the coughing is not as much. I do want something to eat and don't when I get it. Some of the strangest things I am craving pickles and buffalo shrimp. I am wanting odd things to eat.
10/6/16 At 3:37PM, cleaned left deltoid with alcohol and gauze, injection syringe needle into left deltoid after feeling 2 fingerbreadths below acromial process. Pt. cooperative. Patient moved away from needle stick pronto on insertion injection of Influenza vaccine causing needle scratch on left deltoid area approximately 11/2 inch. Cleaned with alcohol and gauze, applied 3 bandaids.
tension headache; brain fog; This spontaneous case was reported by a patient and describes the occurrence of TENSION HEADACHE (tension headache) and FEELING ABNORMAL (brain fog) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced TENSION HEADACHE (tension headache) and FEELING ABNORMAL (brain fog). At the time of the report, TENSION HEADACHE (tension headache) and FEELING ABNORMAL (brain fog) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information provided.  No treatment information provided.   This case was linked to MOD-2021-258051 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Non significant follow up received on 15-JUL-2021. Contains updated secondary reporter's contact information.
This case was reported by a healthcare professional via a sales representative and described the occurrence of unspecified adverse event in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of FLULAVAL (unknown) from lot number AFLL032AA. The sales representative reported the lot number to be AFL1A032AA but reported that he was unsure if the fourth character was a 1 of L. At an unspecified time after vaccination with FLULAVAL, the subject experienced adverse event event and pharmaceutical product complaint. At the time of reporting the outcome of the unspecified adverse event was unspecified. Per the source document it was reported that the nurse questioned if "there were any hot lots." The nurse reported that she was not going to use any more FLULAVAL. It was noted that this was a legal case. The nurse reported that this event occurred in two other subjects. See GSK manufacturer case number A0705244A and A0705245A for details.
Flushing of hands and forearm. I suspect feet and legs below the knee. I didn?t check feet of legs but felt hot and tingling.Onset within first 2 minutes but passed quickly . For sure improved at 10 minute mark but probably improved at 5 minutes.
2 weeks after MMR vaccine, patient began bruising on back and buttocks.  Bruising became more pronounced over next several weeks and more widespread. For approximately 1 month, pt had a fine red rash on his feet.
Right arm soreness, swelling, difficulty sleeping secondary to arm pain.  No relief of symptoms despite Motrin 800 mg qid.  Symptoms for 7 days.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related injuries. In 2007, a physician administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2009, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
no adverse event; HBP called to report a TE with PROQUAD from 8/19/2022. Administered to this patient on 1/7/2023.; This spontaneous report has been received from a physician referred to an 1-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided.  On 07-JAN-2023, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live, recombinant human albumin (rha) (PROQUAD) injection, 0.5 milliliter (ml) (valid lot number U039261 [expiration date 09-JUN-2023]) (dose number, frequency, route of administration vaccination scheme, and anatomical location were not provided), administered for prophylaxis, after a temperature excursion (product storage error).  No adverse effects reported.
Large red reaction in area where PENTACEL was given. Warm to touch; child cried every time the area was touched. Happened immediately after injection.
After getting the 2nd shot everything went haywire; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (After getting the 2nd shot everything went haywire) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced ADVERSE EVENT (After getting the 2nd shot everything went haywire). At the time of the report, ADVERSE EVENT (After getting the 2nd shot everything went haywire) outcome was unknown.            relevant concomitant products usage were not reported by the reporter.treatment details not included.
Her daughter's mother in law tested positive after getting the first dose of the vaccine; Her daughter's mother in law tested positive after getting the first dose of the vaccine; This is a spontaneous report from a contactable consumer (patient relative/her daughter's mother-in-law). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unknown date (Lot number: UNKNOWN) as a single dose for COVID-19 immunization. The patient's medical history and concomitant were not reported. Patient tested positive after getting the first dose of the vaccine on unspecified date. The outcome of the events was unknown.
Child received vaccination of Dtap on 7/7/05 at public health. 7/8/05 Mother called child's rgt thigh red, swollen, hard, blotchy red called MD. Instructed to give Tylenol and cold compresses to area. 7/9/05 Mother reported swelling along with redness and hardness feeling better MD worried.
Fatigue, headache, fever of 100 degrees.  Treated with ibuprofen to relieve symptoms.
Pt screamed for 3 hrs p/vax; Mom didn't notify clinic until 4 mo check;
unknowm side effects due to the vaccine being administered today; Patient received bivalent vaccine as first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of IMMUNISATION REACTION (unknowm side effects due to the vaccine being administered today) and WRONG PRODUCT ADMINISTERED (Patient received bivalent vaccine as first dose) in a 95-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7164B) for COVID-19 prophylaxis.     It was unknown if patient had any medical history, allergy, concomitant diseases and risk factor. Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 19-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jun-2023, the patient experienced IMMUNISATION REACTION (unknowm side effects due to the vaccine being administered today) and WRONG PRODUCT ADMINISTERED (Patient received bivalent vaccine as first dose). At the time of the report, IMMUNISATION REACTION (unknowm side effects due to the vaccine being administered today) and WRONG PRODUCT ADMINISTERED (Patient received bivalent vaccine as first dose) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was provided.
bad sinus infection; radiating chest pain; Having low grade fevers; Headache; body ache; nausea; diarrhea; This is a spontaneous report received from contactable consumer (patient) a female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot/batch number was not reported) via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced after 45 minutes of second dose, low grade fevers, headaches, body aches, nausea, bad sinus infection, diarrhea, and radiating chest pain. The outcome of events was unknown.  No follow-up attempts were needed. Information about lot/batch number could not be obtained.
Obtained 3rd booster dose of Pfizer (vaccinated w/Moderna in 1/21 and 2/21) due to duration of prior vaccination and upcoming travel to, a Delta variant hotspot. Experienced fever, severe left arm pain, and chills starting at approximately midnight on 8/4. Using 1000mg doses of OTC Tylenol to relieve symptoms.
Occluded left internal carotid artery. No family history of stroke on either side. Tachycardia in the 140's to 150's with no prior history of tachycardia.
A report has been received from a Physician concerning a 48 year old, female subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 23-SEP-2014. The patient experienced chills, muscle aches and headache. The patient recovered from the event of chills and muscle aches on an unspecified date and at the time of reporting, the event of headache was ongoing. The report was considered to be non-serious.
Within less than 12 hours of vaccine administration (to my right arm) I began feeling pain and a burning sensation in my left shoulder/arm.  After a full week of pain (which started to increase), I scheduled an appointment with my primary care physician, who examined me, and referred me to an imaging company to have an x-ray done. Over the next week, the pain started to taper off but simultaneously my muscles became weak and I lost control of the ability to execute certain movements with my left arm.  As an electrician, the inability to put my arm above my head, or push away from my body with any notable strength has rendered me occupational useless.  When the x-ray did not show anything telling, I was then referred to an orthopedic surgeon. This surgeon examined me, and before the end of the exam had come to the conclusion that I have parsonage turner syndrome (PTS). In order to verify this, he referred me to a place to receive a MRI.  Upon my second visit with this physician, we reviewed the results of the MRI which came back with no sign of undue wear or other known damage, and he concluded that his original diagnosis was correct and referred me to Dr. for a thorough EMG test.  Dr. did a very thorough EMG test where he found that two specific muscles and their corresponding nerves were inactive.  He then assured me that I have not only have "classic symptoms of parsonage turner syndrome" and agreed with that diagnosis: but beyond that, he answered my questions.  Dr. assured me that over his long career "he has seen several adverse effects due to auto immune responses due to vaccines in the past, and that he believes my predicament was caused by the vaccine I had received in the same day when my symptoms started".
Patient received Tdap and shingrix vaccines on 4/7/23. She reported on 4/10/23 she developed hives on her back and bilateral arms later on 4/7/23 as well as cough productive of green sputum. She was advised to take benadryl as needed and follow up in office on 4/11/23. She followed up for an appointment on 4/11/23 and also reported hives on her legs. Cough thought to be unrelated to vaccines. She was prescribed methylprednisolone 4mg dose pack and famotidine. She was advised to continue her usual levocetirizine and montelukast taken for allergies. She followed up on 4/13/23 and noted improvement in symptoms. Reached out to patient today and she reports resolution of hives.
My vision went completely blurry within 20 minutes. I went to the emergency room thinking it had something to do with my Diabetes, but they gave me a CT scan and something to take for my migraines. The scan showed that it was just a new side effect with my severe migraines. I also caught COVID-19 in December. It started with a sore throat. I tested negative when I went into urgent care the first time, but that Sunday after I retested at home and my results came back positive. I did a Telehealth and got prescribed PAXLOVID. I tested again and was able to go back to work after 10 days.
Red, itchy area on Left upper arm that is approx 3 inches x 6 inches. Area is swollen, painful, sore, and hot to the touch. Patient states she has never reacted to this degree with any other vaccination. States a small amount of relief after taking 25mg BENADRYL tablet. Have asked patient to take a picture of the site with a ruler to get proper scale, continue with BENADRYL tabs and add to that lidocaine cream rubbed into site area. Patient is also advised not to receive the second SHINGRIX vaccine.
has stopped walking on his own / unable to walk by himself; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 48-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization; Bnt162b2 (Dose 2), for COVID-19 immunization. The following information was reported: GAIT INABILITY (non-serious) with onset 2022, outcome "unknown", described as "has stopped walking on his own / unable to walk by himself". Additional information: A father was calling on behalf of his son. His son received 3 Pfizer COVID vaccines and son has stopped walking on his own. The reporter requested information on the side effects of the Pfizer COVID 19 vaccine. It was reported that the patient was a special needs patient, but was walking before, from couch to chair and chair to couch. His son has been in a rehabilitation center. The reporter stated that when he visited his son before COVID (pandemic), his son was walking on his own before he got the vaccine. After COVID (pandemic), the reporter has been unable to visit his son so only was able to check on him via phone every day. His son has received 3 doses of the Pfizer vaccine. The reporter found out about 4 months ago that his son was now unable to walk by himself and needs someone to hold him up otherwise he falls and loses his balance. The providers don't know why this was happening and if it's the vaccine or not.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Had first Moderna dose on April 10, 2021.  Woke up a bit after falling asleep around 10:30 p.m. on April 11 with severe nausea that kept me awake all night.  Also had chills and pins and needles sensation in extremities and a slight headache.  Nausea lasted about 12 hours.  Then noticed on April 12 that my tinnitus that I have had since around age 20 had gotten worse.  Has not gone back to way it was before the 1s Moderna dose.